Robert Landewé
Impact in
- Rheumatology top 0.01%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Hematology top 0.1%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 449
- Spondyloarthritis Studies and Treatments 278
- Rheumatoid Arthritis Research and Therapies 232
- Systemic Lupus Erythematosus Research 29
- Immunology 72
- Psoriasis: Treatment and Pathogenesis 55
- Co-authors
- D. M. van der HEIJDE (251 shared papers)Maxime Dougados (86 shared papers)Sofía Ramiro (103 shared papers)Joachim Sieper (34 shared papers)Jürgen Braun (31 shared papers)Xenofon Baraliakos (47 shared papers)Martín Rudwaleit (33 shared papers)Astrid M van Tubergen (52 shared papers)
- Journals
- Annals of the Rheumatic Diseases (179 papers)Lara D. Veeken (53 papers)RMD Open (47 papers)The Journal of Rheumatology (35 papers)Arthritis Research & Therapy (24 papers)
- Partner nations
- NetherlandsUnited StatesFrance
In The Last Decade
Robert Landewé
548 papers receiving 32.1k citations
Robert Landewé's Hit Papers
Peers
Comparison fields: 5 of 175
- Rheumatology 25.8k
- Hematology 4.7k
- Immunology 6.5k
- Orthopedics and Sports Medicine 2.0k
- Genetics 887
Countries citing papers authored by Robert Landewé
This map shows the geographic impact of Robert Landewé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Landewé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Landewé more than expected).
Fields of papers citing papers by Robert Landewé
This network shows the impact of papers produced by Robert Landewé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Landewé. The network helps show where Robert Landewé may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Landewé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 566 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general Hit paper breakdown → | 2010 | 1232 |
| 2 | The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis Hit paper breakdown → | 2009 | 1229 |
| 3 | Dickkopf-1 is a master regulator of joint remodeling Hit paper breakdown → | 2007 | 1091 |
| 4 | Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis Hit paper breakdown → | 2008 | 765 |
| 5 | Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group Hit paper breakdown → | 2009 | 699 |
| 6 | EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) Hit paper breakdown → | 2006 | 607 |
| 7 | Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores Hit paper breakdown → | 2010 | 593 |
| 8 | Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0 Hit paper breakdown → | 2014 | 582 |
| 9 | Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial Hit paper breakdown → | 2005 | 554 |
| 10 | Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis Hit paper breakdown → | 2014 | 551 |
| 11 | EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis Hit paper breakdown → | 2013 | 496 |
| 12 | 2002 | 488 | |
| 13 | Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty‐two–week, phase III, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group study Hit paper breakdown → | 2008 | 482 |
| 14 | New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS) Hit paper breakdown → | 2009 | 462 |
| 15 | Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial Hit paper breakdown → | 2009 | 439 |
| 16 | Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept Hit paper breakdown → | 2008 | 438 |
| 17 | Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial Hit paper breakdown → | 2008 | 418 |
| 18 | Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis Hit paper breakdown → | 2008 | 408 |
| 19 | Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study Hit paper breakdown → | 2013 | 372 |
| 20 | 2009 | 328 |
About Robert Landewé
Robert Landewé is a scholar working on Rheumatology, Immunology, Hematology, Orthopedics and Sports Medicine and Pathology and Forensic Medicine, having authored 566 papers that have together received 33.4k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (278 papers), Rheumatoid Arthritis Research and Therapies (232 papers), Psoriasis: Treatment and Pathogenesis (55 papers), Autoimmune and Inflammatory Disorders Research (36 papers), Systemic Lupus Erythematosus Research (29 papers), Bone and Joint Diseases (17 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (12 papers) and Chronic Lymphocytic Leukemia Research (11 papers). The work is most often cited by research in Rheumatology (25.8k citations), Hematology (4.7k citations), Immunology (6.5k citations), Orthopedics and Sports Medicine (2.0k citations) and Genetics (887 citations). Robert Landewé has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include D. M. van der HEIJDE, Maxime Dougados, Sofía Ramiro, Joachim Sieper, Jürgen Braun, Xenofon Baraliakos, Martín Rudwaleit, Astrid M van Tubergen, Walter P. Maksymowych and Josef S Smolen. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, RMD Open, The Journal of Rheumatology and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.